Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) Read more about Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma Read more about Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN Read more about SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial Read more about Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials Read more about Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Implementation and Effectiveness Trial of HN-STAR Read more about Implementation and Effectiveness Trial of HN-STAR
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers Read more about A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer Read more about A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer
XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer Read more about XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT Read more about A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT